# OnCo record dmr-001 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/dmr-001/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "dmr-001" ;
  schema:name "DMR-001"@en ;
  schema:description "DMR-001 is an experimental monoclonal antibody from Damora Therapeutics, in phase 1 trials for CALR-mutant essential thrombocythaemia and CALR-mutant myelofibrosis."@en ;
  schema:url <https://onco.cc/drugs/dmr-001/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://damoratx.com/>, <https://damoratx.com/>, <https://clinicaltrials.gov/study/NCT07849231>, <https://clinicaltrials.gov/search?intr=DMR-001> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Monoclonal antibody (subcutaneous, half-life extended)" ;
  onco:cancers <https://onco.cc/cancers/essential-thrombocythaemia/>, <https://onco.cc/cancers/primary-myelofibrosis/> ;
  onco:targets <https://onco.cc/targets/calr/> ;
  onco:companies <https://onco.cc/companies/damora-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07849231/> .